SCHEMBL2581702

SCHEMBL2581702

CCC(CC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.66
L3MBTL1 Q9Y468 4/20 0.61
NPSR1 Q6W5P4 2/20 0.54
POLB P06746 1/20 0.54
HTT P42858 1/20 0.54
TSHR P16473 1/20 0.53
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
NPC1 O15118 1/20 0.53
MAPT P10636 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
ALDH1A1 P00352 3/20 0.50
LMNA P02545 2/20 0.50
KDM4E B2RXH2 2/20 0.50
PTPN1 P18031 2/20 0.48
HPGD P15428 3/20 0.47
MAPK1 P28482 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12158645 1.00 ATM (0.66) ATML3MBTL1NPSR1POLBHTT
SCHEMBL28114650 1.00 ATM (0.66) ATML3MBTL1NPSR1POLBHTT
SCHEMBL28010708 0.90 L3MBTL1 (0.59) ATML3MBTL1NPSR1POLBHTT
SCHEMBL12158725 0.90 L3MBTL1 (0.59) ATML3MBTL1NPSR1POLBHTT
SCHEMBL2579321 0.90 L3MBTL1 (0.59) ATML3MBTL1NPSR1POLBHTT
SCHEMBL12158733 0.89 L3MBTL1 (0.57) ATML3MBTL1NPSR1POLBHTT
SCHEMBL2587322 0.89 L3MBTL1 (0.57) ATML3MBTL1NPSR1POLBHTT
SCHEMBL12158730 0.89 L3MBTL1 (0.57) ATML3MBTL1NPSR1POLBHTT
SCHEMBL12158732 0.89 L3MBTL1 (0.57) ATML3MBTL1NPSR1POLBHTT
SCHEMBL28837037 0.89 L3MBTL1 (0.57) ATML3MBTL1NPSR1POLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104530122-B Dinaphthol phosphoramidite ligand, its synthetic method and the application thereof of dendrimer, dendritic polymer load 商丘师范学院 2016-11-30 CN disclosed
CN-102260131-B Method for mirror selective addition of alkenones NAT UNIV TSING HUA 2013-11-06 CN disclosed
US-8304581-B2 Method of enantioselective addition to enones NATIONAL TSING HUA UNIVERSITY (TW) 2012-11-06 US disclosed
CN-102260131-A Method for mirror selective addition of alkenones 2011-11-30 CN disclosed
US-20110282101-A1 METHOD OF ENANTIOSELECTIVE ADDITION TO ENONES NATIONAL TSING HUA UNIVERSITY (TW) 2011-11-17 US disclosed
US-6380392-B1 COMPLEXES THE PENN STATE RESEARCH FOUNDATION 2002-04-30 US disclosed
CN-1006386-B PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER SHINETSU CHEM IND CO (JP) 1990-01-10 CN disclosed
CN-85107531-A Process for producing vinyl chloride polymer 1987-01-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110282101-A1 METHOD OF ENANTIOSELECTIVE ADDITION TO ENONES CPNE4, ENY2, CYP3A4 ATM 4196/4885L3MBTL1 3225/4885NPSR1 2262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.